The Use of FDG-PET in conjunction with PSMA-PET in Prostate Cancer

被引：0
|
作者：
Gokhale, Saket [1 ]
Kuang, Angie [1 ]
Teichner, Eric [1 ]
Subtirelu, Robert [1 ]
Werner, Thomas [2 ]
Hoilund-Carlsen, Poul Flemming [3 ]
Revheim, Mona-Elisabeth [4 ,5 ]
Alavi, Abass [1 ]
Raynor, William [6 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
[2] Univ Penn, Hosp, Philadelphia, PA USA
[3] Univ Southern Denmark, Dept Clin Res, Odense, Denmark
[4] Oslo Univ Hosp, Oslo, Norway
[5] Univ Oslo, Oslo, Norway
[6] Rutgers Robert Wood Johnson Med Sch, New Brunswick, NJ USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2023年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P1083
引用
收藏
页数：2
相关论文
共 50 条
  • [21] PSMA-PET: is the time to say goodbye to metabolic radiopharmaceuticals in prostate cancer?
    Evangelista, Laura
    Alongi, Pierpaolo
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (06) : 1709 - 1711
  • [22] Current role of PSMA-PET imaging in the clinical management of prostate cancer
    Georgakopoulos, Alexander
    Bamias, Aristotle
    Chatziioannou, Sophia
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [23] COMPARING PSMA-PET/CT TO MPMRI AND HISTOPATHOLOGY FOR STAGING PROSTATE CANCER
    Berger, Israel
    Annabattula, Chandra
    Lewis, Jeffrey
    Shetty, Deepa V.
    Winter, Matthew
    Loh, Han
    Varol, Celi
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 51 - 51
  • [24] Complementary role of diffusion weighted imaging and PSMA-PET in PET/MRI of recurrent prostate cancer
    Noto, B.
    Springe, K. Auf Der
    Schaefers, M.
    Rahbar, K.
    Buether, F.
    Kraehling, T.
    Allkemper, T.
    Stegger, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S538 - S539
  • [25] Comment on: Prostate cancer: PSMA-PET better than conventional staging
    Krausewitz, Philipp
    AKTUELLE UROLOGIE, 2024, 55 (01) : 10 - 12
  • [26] PSMA-PET/CT-avid metastatic prostate cancer to the penis
    Mansbridge, Margaret Mary
    Strahan, Andrew
    Parker, Jonathon
    Rhee, Handoo
    BMJ CASE REPORTS, 2020, 13 (03)
  • [27] The phytological future of prostate cancer staging: PSMA-PET and the dandelion theory
    Sathianathen, Niranjan J.
    Geurts, Nicolas
    Nair, Rajesh
    Lawrentschuk, Nathan
    Murphy, Declan G.
    Lamb, Alastair D.
    FUTURE ONCOLOGY, 2017, 13 (20) : 1801 - 1807
  • [28] PSMA-PET GUIDED METASTASIS DIRECTED THERAPY FOR OLIGOMETASTATIC PROSTATE CANCER
    Ghaffar, Umar
    Sharma, Vidit
    Reitano, Giuseppe
    Basourakos, Spyridon P.
    Henning, Grant M.
    Ahmed, Mohamed E.
    Deol, Ekamjit S.
    Johnson, Geoffrey B.
    Andrews, Jack
    Kwon, Eugene D.
    Karnes, Robert J.
    JOURNAL OF UROLOGY, 2024, 211 (05): : E1006 - E1007
  • [29] Recurrent prostate cancer: combined role for MRI and PSMA-PET in 68Ga-PSMA-11 PET/MRI
    Jannusch, Kai
    Bruckmann, Nils Martin
    Morawitz, Janna
    Boschheidgen, Matthias
    Quick, Harald H.
    Herrmann, Ken
    Fendler, Wolfgang P.
    Umutlu, Lale
    Stuschke, Martin
    Hadaschik, Boris
    Antoch, Gerald
    Schimmoeller, Lars
    Kirchner, Julian
    EUROPEAN RADIOLOGY, 2024, 34 (07) : 4789 - 4800
  • [30] THE CHOPP STUDY: CHANGING TREATMENT PATHWAYS IN OLIGOMETASTATIC PROSTATE CANCER WITH USE OF PSMA-PET/CT
    Schmidt, Andrew
    Goh, Jeffrey
    Bhatt, Manoj
    Thomas, Paul
    Suder, Aneta
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 58 - 58
12345